These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6327414)

  • 1. Epidermodysplasia verruciformis in lepromatous leprosy. Report of 2 cases.
    Jacyk WK; Lechner W
    Dermatologica; 1984; 168(4):202-5. PubMed ID: 6327414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lepromatous leprosy with extensive seborrheic keratoses and proliferative verruca vulgaris.
    Jablonska S
    Int J Dermatol; 1996 Aug; 35(8):606. PubMed ID: 8854173
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidermodysplasia verruciformis versus disseminated verrucae planae: is epidermodysplasia verruciformis a generalized infection with wart virus?
    Jablonska S; Orth G; Jarzabek-Chorzelska M; Rzesa G; Obałek S; Glinski W; Favre M; Croissant O
    J Invest Dermatol; 1979 Mar; 72(3):114-9. PubMed ID: 217936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin.
    Majewski S; Jabłońska S
    Arch Dermatol; 1995 Nov; 131(11):1312-8. PubMed ID: 7503577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermodysplasia verruciformis. Skin carcinoma containing human papillomavirus type 5 DNA sequences and primary hepatocellular carcinoma associated with chronic hepatitis B virus infection in a patient.
    van Voorst Vader PC; Orth G; Dutronquay V; Driessen LH; Eggink HF; Kallenberg CG; The TH
    Acta Derm Venereol; 1986; 66(3):231-6. PubMed ID: 2426900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lepromatous leprosy in a case of epidermodysplasia verruciformis - A coincidence or a result of defective cell-mediated immunity?
    Tripathy DM; Neema S; Kinra P; Sinha P
    Int J Mycobacteriol; 2021; 10(2):210-213. PubMed ID: 34558478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased natural killer cell activity in patients with epidermodysplasia verruciformis.
    Kamiński M; Pawińska M; Jablonska S; Szmurło A; Majewski S; Orth G
    Arch Dermatol; 1985 Jan; 121(1):84-6. PubMed ID: 2981519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papilloma virus 5-DNA in a carcinoma of an epidermodysplasia verruciformis patient infected with various human papillomavirus types.
    Pfister H; Gassenmaier A; Nürnberger F; Stüttgen G
    Cancer Res; 1983 Mar; 43(3):1436-41. PubMed ID: 6297727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis.
    Pereira de Oliveira WR; Carrasco S; Neto CF; Rady P; Tyring SK
    J Dermatol; 2003 Mar; 30(3):203-9. PubMed ID: 12692356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53 expression and human papillomavirus infection in transplant recipients and in patients with epidermodysplasia verruciformis.
    McGregor JM; McKee PH; Khorshid M; Proby CM
    Br J Dermatol; 1996 Feb; 134(2):374. PubMed ID: 8746364
    [No Abstract]   [Full Text] [Related]  

  • 11. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA.
    Weissenborn SJ; Höpfl R; Weber F; Smola H; Pfister HJ; Fuchs PG
    J Invest Dermatol; 1999 Jul; 113(1):122-6. PubMed ID: 10417630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis.
    Majewski S; Malejczyk J; Jablonska S; Misiewicz J; Rudnicka L; Obalek S; Orth G
    J Am Acad Dermatol; 1990 Mar; 22(3):423-7. PubMed ID: 2155952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen presentation and T-cell activation in epidermodysplasia verruciformis.
    Cooper KD; Androphy EJ; Lowy D; Katz SI
    J Invest Dermatol; 1990 Jun; 94(6):769-76. PubMed ID: 2162366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific cell-mediated immunity in patients with epidermodysplasia verruciformis and plane warts.
    Haftek M; Jabłonska S; Orth G
    Dermatologica; 1985; 170(5):213-20. PubMed ID: 2989014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus particles in epidermodysplasia verruciformis with carcinoma.
    Yabe Y; Okamoto T; Omori S; Tanioku K
    Dermatologica; 1969; 139(2):161-4. PubMed ID: 4309378
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of HLA antigens in familial and non-familial epidermodysplasia verruciformis.
    Wojtulewicz-Kurkus J; Gliński W; Jabłońska S; Podobińska I; Obałek S
    Dermatologica; 1985; 170(2):53-8. PubMed ID: 3856540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: the role of local immunosurveillance.
    Majewski S; Jablonska S
    Am J Med Sci; 1992 Sep; 304(3):174-9. PubMed ID: 1335684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidermodysplasia verruciformis--an example of viral carcinogenesis].
    Fräki J; Väätäinen N; Syrjänen KJ
    Duodecim; 1986; 102(1):36-41. PubMed ID: 3004884
    [No Abstract]   [Full Text] [Related]  

  • 19. Oncogenic potential of human papillomaviruses epidermodysplasia verruciformis: a counterpart of Shope papilloma-carcinoma complex.
    Jabłonska S; Orth G; Obalek S; Croissant O; Jarzabek-Chorzelska M; Favre M; Kremsdorf D
    Arch Geschwulstforsch; 1983; 53(3):207-15. PubMed ID: 6311135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidermodysplasia verruciformis associated with chromosomal abnormality].
    Sawada Y; Ohashi M; Kishi K; Ikeuchi T
    Nihon Hifuka Gakkai Zasshi; 1984 Mar; 94(3):201-5. PubMed ID: 6088856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.